Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 20:16:1612194.
doi: 10.3389/fendo.2025.1612194. eCollection 2025.

Age-stratified anti-Müllerian hormone (AMH) nomogram: a comprehensive cohort study including 22.920 women

Kiper Aslan  1 , Isil Kasapoglu  1 , Bahadir Kosan  1 , Aylin Tunali  1 , Ilayda Tellioglu  1 , Gurkan Uncu  1
Affiliations

Age-stratified anti-Müllerian hormone (AMH) nomogram: a comprehensive cohort study including 22.920 women

Kiper Aslan et al. Front Endocrinol (Lausanne). .

Abstract

Background: Infertility rates have been rising globally, necessitating accurate assessment tools for ovarian reserve. Anti-Müllerian hormone (AMH) is a key biomarker for evaluating ovarian reserve, yet age-stratified reference data remain limited. Establishing an AMH nomogram could enhance fertility counseling and treatment planning.

Objective: To develop an age-stratified AMH nomogram to improve the understanding of ovarian reserve across reproductive ages and assist in comparing individual AMH values with age-specific thresholds, aiding in the baseline infertility work-up.

Methods: This retrospective cohort study analyzed AMH test results from a tertiary university hospital's electronic database between April 2015 and June 2024. Data were collected from various departments, excluding women younger than 18 or older than 45 years. Median AMH levels and interquartile ranges were calculated for each age group. The prevalence of diminished ovarian reserve (DOR), defined as AMH <1.2 ng/mL, was determined. Statistical analyses, including correlation testing and subgroup comparisons across different clinical settings, were performed using SPSS version 22 (IBM Corp., Armonk, NY, USA).

Results: A total of 22,920 AMH results were analyzed after excluding patients outside the 18-45 age range and those with incomplete data. More than half of the AMH tests were from women aged 24-33 years. The results demonstrated a significant negative correlation between age and AMH levels, with a median AMH value dropping below 1.2 ng/mL by age 36. The prevalence of DOR increased from 15.9% at age 18 to 96% at age 45. Additionally, women from the Endometriosis Unit had significantly lower AMH levels (median 1.6 ng/mL) compared to other departments (median 2.03 ng/mL). The age-stratified AMH distribution remained consistent even when patients from ART (Assisted Reproductive Technology) centers, REI (Reproductive Endocrinology and Infertility), and the Endometriosis Unit were excluded.

Conclusion: This study provides an age-stratified AMH nomogram that can serve as a valuable tool for clinicians to assess ovarian reserve more accurately. The sharp decline in AMH levels, particularly after age 36, emphasizes the need for timely fertility evaluations and interventions, particularly in populations at risk for diminished ovarian reserve, such as those with endometriosis.

Keywords: AMH; age stratification; diminished ovarian reserve; endometriosis; infertility; nomogram; ovarian reserve.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Distribution of AMH & women age.
Figure 2
Figure 2
Median AMH value in each age (ng/ml).
Figure 3
Figure 3
Presence of diminished ovarian reserve in each age.
Figure 4
Figure 4
Distribution of AMH Samples.
Figure 5
Figure 5
Presence of diminished ovarian reserve in each department & pairwise comparisons.
Figure 6
Figure 6
Women age & departments.
See this image and copyright information in PMC

References

    1. Sun H, Gong TT, Jiang YT, Zhang S, Zhao YH, Wu QJ. Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from a global burden of disease study, 2017. Aging (Albany NY). (2019) 11:10952–91. doi: 10.18632/aging.102497 - DOI - PMC - PubMed
    1. Recent advances in medically assisted conception. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. (1992) 820:1–111. - PubMed
    1. Practice Committee of the American Society for Reproductive Medicine . Electronic address: asrm@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. (2021) 116:1255–65. doi: 10.1016/j.fertnstert.2021.08.038 - DOI - PubMed
    1. Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. (2017) 217:129–40. doi: 10.1016/j.ajog.2017.02.027 - DOI - PubMed
    1. The Unexplained Infertility guideline group. Romualdi D, Ata B, Bhattacharya S, Bosch E, Costello M, et al. Evidence-based guideline: Unexplained Infertility. Hum Reprod. (2023) 38(10):1881–90. Available online at: https://www.eshre.eu/guideline/UI. - PMC - PubMed

LinkOut - more resources